Renvela 800 mg sachets is used for adult patients who are on hemodialysis with stage 4 and 5 chronic kidney disease (CKD), to manage hyperphosphatemia. Renvela 800 mg sachets is a phosphate binding medicine, used to lower high blood phosphorus levels in patients who are on dialysis. When you take Renvela 800 mg sachets with meals, it binds to dietary phosphate, and prevents its absorption in your body. Dialysis help to remove some phosphate from your blood, but it is difficult to takeout enough to keep your phosphate levels balanced. As blood phosphate levels decreases, possibly of the risk of heart disease and strokes decrease.

• Hyperphosphatemia
• Chronic kidney disease (CKD)

Renvela 800 mg sachets lower high blood phosphorus in a dialysis patient suffering from kidney disease. As blood phosphate levels decreases, possibility of the risk of heart disease and strokes decrease.

Renvela 800 mg sachets may cause adverse effects. Inform your doctor if any of these symptoms get severe or that bother you for a longer period.

• Headache
• Diarrhea
• Stomach upset
• Nausea
• Vomiting
• Cough
• Constipation
• Metabolic acidosis

• Trouble breathing
• Chest pain
• Allergic reaction
• Severe dizziness

Take Renvela 800 mg sachets orally as directed by your doctor. Swallow the whole tablet. Do not crush, chew, or split the tablet. The dosage is decided by the doctor based on your medical condition. Inform your doctor if you are taking any other medications to lower your phosphate levels.

Renvela 800 mg sachets is a phosphate binding medicine, used to lower high blood phosphorus levels in patients who are on dialysis. When you take Renvela 800 mg sachets with meals, it binds to dietary phosphate, and prevents its absorption in your body.